AMCP Trump Administration Actions Tracker
AMCP tracks presidential actions affecting the practice of managed care pharmacy. This tracker includes executive orders (EOs), memorandums, proclamations, and nominations released by the Trump administration on or after Jan. 20, 2025.
Jump to: Health Care | Federal Workforce/General Government | Trade Tariffs | Nominees/Appointees | HHS Leadership
Health Care
| Action | Number/Name | Issue Date | Effect | Timeframe | Link | Litigation |
|---|---|---|---|---|---|---|
| Executive Order | # - Expanding Access to In Vitro Fertilization | 2/18/25 | Instructs the Assistant to the President for Domestic Policy to develop a list of policy recommendations on protecting access to IVF treatments, as well as opportunities to reduce OOP and health plan costs. | Recommendations must be submitted within 90 days of the date of this order. |
| N/A |
| Executive Order | 14214 -Keeping Education Accessible and ending COVID-19 Vaccine Mandates in Schools | 2/15/25 | Opposes the use of federal funding for schools (K-12 and higher education) or agencies that require COVID-19 vaccination. Also directs Dept. of Edu. to issue guidance to schools on their legal obligations with respect to COVID-19 vaccine mandates. | Directs the Secretary of Education to provide a plan to end COVID-19 vaccine mandates in schools within 90 days of the order. | N/A | |
| Executive Order | 14212 - Establishing the President’s Make America Healthy Again Commission | 2/13/25 | Directs federal health departments and agencies to combat the causes of chronic disease, including obesity, diabetes, and mental health disorders. Also establishes a Make America Healthy Again Commission, chaired by the HHS Secretary, which is tasked with studying the cause of and providing policy recommendations to alleviate childhood chronic disease. | Within 100 days of the enactment of this order, the Commission must submit a Make our Children Healthy Again Assessment. Within 180 days, the Commission must submit a Make Our Children Healthy Again Strategy report. | N/A | |
| Executive Order | 14187 – Protecting Children from Chemical and Surgical Mutilation | 1/28/25 | Seeks to prohibit or limit federal support for gender affirming care for transgender children. Directs HHS to provide new guidance and resources on care for children experiencing gender dysphoria and rescind prior guidance on gender affirming care for children. Excludes pediatric transgender surgeries from TRICARE coverage and Federal Employee Health Benefits coverage. Directs DOJ to prioritize enforcement of protections against pediatric genital mutilation, and work with Congress to develop a private right of action for children and parents of children who have transitioned. Also expands the definition of “child” to include those under 19 years of age. | N/A | Federal Register | Injunction filed 2/4/25 U.S. District Judge Brendan A. Hurson granted temporary restraining order on 2/13/25. |
| Executive Order | 14182 – Enforcing the Hyde Amendment | 1/24/25 | Ends the use of federal dollars to promote or fund abortion, revokes two EOs on reproductive health care, 14076 and 14079. Passed in 1976, the Hyde amendment restricts federal funding for elective abortions. | N/A | ||
| Memorandum | Memorandum for the Secretary of State, the Secretary of Defense, the Secretary of Health and Human Services, the Administrator of the United States for International Development | 1/24/25 | Directs HHS, the Department of State, and USAID to reinstate the Mexico City Policy. The Mexico City Policy blocks foreign non-governmental organizations who provide abortion counseling from receiving federal funding. | N/A | White House | N/A |
| Executive Order | 14155 - Withdrawing the United States from the World Health Organization | 1/20/25 | Withdraws the U.S. from the WHO, requires NSC to establish protocols to safeguard public health, rescinds 2024 Global Health Security Strategy and Biden EO 13987 on COVID-19 mobilization | N/A | Federal Register | N/A |
| Memorandum | Delivering Price Relief for American Families and Defeating the Cost of Living Crisis | 1/20/25 | Directs all federal agencies to improve the affordability of necessary goods and services, includes action to: “eliminate unnecessary administrative expenses and rent-seeking practices that drive up healthcare costs.” | N/A | White House Fact Sheet | N/A |
| Executive Order | 14148 – Initial Rescissions of Harmful Executive Orders and Actions | 1/20/25 | Revokes dozens of executive actions from the Biden Administration, including several health care-related actions on COVID-19 pandemic preparedness, health equity, and drug pricing. | N/A | White House AMCP Policy Brief | N/A |
Jump to: Health Care | Federal Workforce/General Government | Trade Tariffs | Nominees/Appointees | HHS Leadership
Federal Workforce/General Government
| Action | Number/Name | Issue Date | Effect | Timeframe | Link | Litigation | |
|---|---|---|---|---|---|---|---|
| Executive Order | Commencing The Reduction of the Federal Bureaucracy | 2/19/25 | Proposal to abolish a specific group of government agencies as a way to decrease the federal government's size; it mandates that the leaders of those agencies verify adherence within a two-week timeframe. | Within 14 days of this order | White House | ||
| Executive Order | # - Ensuring Accountability for All Agencies | 2/18/25 | Aims to increase administrative oversight of independent federal agencies. Directs Director of the Office of Management and Budget (OMB) to establish management objectives and submit reports to the President on agency performance. OMB is directed to review regulatory actions to ensure they remain consistent with the administration’s priorities, and OMB may adjust apportionment for independent agencies inconsistent with the President’s priorities. Also clarifies the President and Attorney General’s power to provide “authoritative interpretations” of law. | Within 60 days of the date of this order, or the completion of implementation guidance | Litigation expected | ||
| Memorandum | Memorandum for the Heads of Executive Departments and Agencies on Advancing United States Interests When Funding Nongovernmental Organizations | 2/6/25 | Instructs federal agencies to review all funding that agencies provide to Nongovernmental Organizations (NGOs). Agency heads are instructed to align funding decisions with the goals and priorities of the Trump administration. | N/A | White House | N/A | |
| Executive Order | 14192 – Unleashing Prosperity Through Deregulation | 1/31/25 | For FY 2025, executive departments or agencies must identify 10 existing regulations to be repealed, for every new regulation promulgated. The costs of newly elected regulation shall be offset by the elimination of existing costs of the 10 repealed regulations. | Effective for FY 2025 (Oct. 1, 2024 – Sept. 30, 2025) | Federal Register Fact Sheet | ||
| Memorandum | Memorandum for Heads of Executive Departments and Agencies on Temporary Pause of Agency Grant, Loan, and Other Financial Assistance Programs | 1/27/25 | Established a temporary pause on all federal financial assistance programs | Memo withdrawn | Office of Management and Budget | Injunction filed on 2/3/25, U.S. District Judge Loren L. AliKhan filed a temporary restraining order | |
| Memorandum | Regulatory Freeze Pending Review | 1/20/25 | Requires all executive departments and agencies to withhold rulemaking prior to a review by a Trump appointed official, agencies must withdraw rules that have not been published by the Federal Register, agencies must consider postponing rules that have not been published/taken effect for 60 days | 60 days, starting at 12:00pm ET on 1/20/25 | White House |
Jump to: Health Care | Federal Workforce/General Government | Trade Tariffs | Nominees/Appointees | HHS Leadership
Trade Tariffs
| Action | Number/Name | Issue Date | Effect | Timeframe | Link | Litigation |
|---|---|---|---|---|---|---|
| Executive Order | EO 14195 - Imposing Duties to Address the Synthetic Opioid Supply Chain in the People’s Republic of China | 2/1/25 | Imposes a 10 percent tariff on Chinese goods starting February 4; revokes de minimis for these products; includes a clause for escalation if there is retaliation; states tariffs will be lifted once China addresses the opioid crisis. | N/A | Federal Register | |
| Executive Order | EO 14194 - Imposing Duties to Address the Situation at Our Southern Border | 2/1/25 | Imposes a 25% tariff on Mexican goods starting February 4; revokes de minimis for these products; includes a clause for escalation if there is retaliation; states tariffs will be lifted once Mexico resolves the "illegal migration and drug crisis." Paused on 2/3/25 until 3/4/25. | Paused until 3/4/25 | Federal Register White House | |
| Executive Order | EO 14193 - Imposing Duties to Address the Flow of Illicit Drugs Across Our Northern Border | 2/1/25 | Imposes a 25% tariff on Canadian goods starting February 4; revokes de minimis for these products; includes a clause for escalation if there is retaliation; states tariffs will be lifted once Canada resolves the "public health crisis" (illicit drugs). Paused on 2/3/25 until 3/4/25. | Federal Register White House |
Jump to: Health Care | Federal Workforce/General Government | Trade Tariffs | Nominees/Appointees | HHS Leadership
Nominees/Appointees
White House Positions | |
|---|---|
| Chief of Staff | Susie Wiles |
| Deputy Chief of Staff | Dan Scavino |
| Deputy Chief of Staff for Policy | Stephen Miller |
| Deputy Chief of Staff for Legislative, Political, and Public Affairs | James Blair |
| Deputy Chief of Staff for Communications and Personnel | Taylor Budowich |
| White House Counsel | William McGinley |
| Office of Management & Budget Director | Russell Vought (Director)* Don Dempsey (Health Program Associate Director) |
| Domestic Policy Council (DPC) | Vince Haley (Director) Theo Merkel (Special Assistant to the President - Health Care) |
| National Economic Council | Kevin Hassett (Director) Joel Zinberg (Health Care) |
| President's Council of Advisors on Science and Technology | Lynne Parker (Executive Director) David Sacks (Special Advisor for AI and Crypto) |
| White House Office of Science and Technology Policy Director* | Michael Kratsios |
*Position requires Senate confirmation | |
Jump to: Health Care | Federal Workforce/General Government | Trade Tariffs | Nominees/Appointees | HHS Leadership
Department of Health & Human Services and Sub-Agency Leadership
| Secretary of Health and Human Services | Robert F. Kennedy |
| Deputy Secretary of Health and Human Services | Vacant, nomination pending for James O'Neil |
| Chief of Staff | Heather Flick |
| Deputy Chief of Staff | Stefanie Spear (Principal Deputy, external focus), Scott Rowell (Operations), Hannah Anderson (Policy) Counselors: TBA |
| Administrator of the Centers for Medicare and Medicaid Services | Vacant, nomination pending for Mehmet Oz Chief of Staff: Stephanie Carlton |
| U.S. Surgeon General | Vacant, nomination pending for Janette Nesheiwat |
| Director of the National Institutes of Health | Vacant, nomination pending for Jayanta Bhattacharya Dr. Matthew J. Memoli (Acting) |
| Commissioner of Food and Drugs | Vacant, nomination pending for Martin Makary Dr. Sara Brenner (Acting) |
| Director of the Centers for Disease Control and Prevention | Vacant, Nomination pending for David Weldon Dr. Susan Monarez (Acting) |
| Administrator of the Health Resources and Services Administration | Thomas J. Engels |
| Assistant Secretary for Preparedness and Response | Vacant, nomination pending for Houston Park |
| Director of the Advanced Research Projects Agency for Health | Vacant |
| Deputy Administrator for the Center for Medicare | Ing-Jye Cheng (Acting) |
| Director of the Center for Medicaid & CHIP Services | Drew Snyder |
| Deputy Administrator for the Center for Medicare and Medicaid Innovation | Abe Sutton |
